Dice.camp

UK<a href="https://www.europesays.com/uk/251559/" rel="nofollow noopener" translate="no" target="_blank">https://www.europesays.com/uk/251559/</a> Two-faced gene variant appears good for men, bad for women <a href="https://pubeurope.com/tags/CincinnatiChildren" class="mention hashtag" rel="nofollow noopener" target="_blank">#CincinnatiChildren</a>'sHospitalMedicalCenter <a href="https://pubeurope.com/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a>&MedicalDiscoveries <a href="https://pubeurope.com/tags/Genetics" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genetics</a> <a href="https://pubeurope.com/tags/HealthCare" class="mention hashtag" rel="nofollow noopener" target="_blank">#HealthCare</a>&Hospitals <a href="https://pubeurope.com/tags/Pharmaceuticals" class="mention hashtag" rel="nofollow noopener" target="_blank">#Pharmaceuticals</a> <a href="https://pubeurope.com/tags/PollsAndResearch" class="mention hashtag" rel="nofollow noopener" target="_blank">#PollsAndResearch</a> <a href="https://pubeurope.com/tags/Science" class="mention hashtag" rel="nofollow noopener" target="_blank">#Science</a> <a href="https://pubeurope.com/tags/surveys" class="mention hashtag" rel="nofollow noopener" target="_blank">#surveys</a> <a href="https://pubeurope.com/tags/UK" class="mention hashtag" rel="nofollow noopener" target="_blank">#UK</a> <a href="https://pubeurope.com/tags/UnitedKingdom" class="mention hashtag" rel="nofollow noopener" target="_blank">#UnitedKingdom</a>

UK<a href="https://www.europesays.com/uk/203060/" rel="nofollow noopener" translate="no" target="_blank">https://www.europesays.com/uk/203060/</a> Treatment that is tailored just for you – Life News <a href="https://pubeurope.com/tags/BLKMaxSuperSpecialityHospital" class="mention hashtag" rel="nofollow noopener" target="_blank">#BLKMaxSuperSpecialityHospital</a> <a href="https://pubeurope.com/tags/CKBirlaHospital" class="mention hashtag" rel="nofollow noopener" target="_blank">#CKBirlaHospital</a> <a href="https://pubeurope.com/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://pubeurope.com/tags/CRISPRTechnology" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPRTechnology</a> <a href="https://pubeurope.com/tags/FortisMemorialResearchInstitute" class="mention hashtag" rel="nofollow noopener" target="_blank">#FortisMemorialResearchInstitute</a> <a href="https://pubeurope.com/tags/FutureOfMedicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#FutureOfMedicine</a> <a href="https://pubeurope.com/tags/GeneEditing" class="mention hashtag" rel="nofollow noopener" target="_blank">#GeneEditing</a> <a href="https://pubeurope.com/tags/GeneticDisorders" class="mention hashtag" rel="nofollow noopener" target="_blank">#GeneticDisorders</a> <a href="https://pubeurope.com/tags/GeneticTesting" class="mention hashtag" rel="nofollow noopener" target="_blank">#GeneticTesting</a> <a href="https://pubeurope.com/tags/Genetics" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genetics</a> <a href="https://pubeurope.com/tags/HealthcareAccessibility" class="mention hashtag" rel="nofollow noopener" target="_blank">#HealthcareAccessibility</a> <a href="https://pubeurope.com/tags/HealthcareInnovation" class="mention hashtag" rel="nofollow noopener" target="_blank">#HealthcareInnovation</a> <a href="https://pubeurope.com/tags/MedicalAdvancements" class="mention hashtag" rel="nofollow noopener" target="_blank">#MedicalAdvancements</a> <a href="https://pubeurope.com/tags/MedicalResearch" class="mention hashtag" rel="nofollow noopener" target="_blank">#MedicalResearch</a> <a href="https://pubeurope.com/tags/PersonalizedMedicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#PersonalizedMedicine</a> <a href="https://pubeurope.com/tags/PrecisionOncology" class="mention hashtag" rel="nofollow noopener" target="_blank">#PrecisionOncology</a> <a href="https://pubeurope.com/tags/RareDiseases" class="mention hashtag" rel="nofollow noopener" target="_blank">#RareDiseases</a> <a href="https://pubeurope.com/tags/Science" class="mention hashtag" rel="nofollow noopener" target="_blank">#Science</a> <a href="https://pubeurope.com/tags/TargetedTherapies" class="mention hashtag" rel="nofollow noopener" target="_blank">#TargetedTherapies</a> <a href="https://pubeurope.com/tags/UK" class="mention hashtag" rel="nofollow noopener" target="_blank">#UK</a> <a href="https://pubeurope.com/tags/UnitedKingdom" class="mention hashtag" rel="nofollow noopener" target="_blank">#UnitedKingdom</a>

Tired CryptidHey folks in <a href="https://disabled.social/tags/Minnesota" class="mention hashtag" rel="nofollow noopener" target="_blank">#Minnesota</a>: If you live near the university, they're doing clinical trials on a treatment for Long COVID! (They're trialling Baricitinib, a JAK inhibitor) <a href="https://kstp.com/kstp-news/top-news/long-covid-patients-urged-to-enroll-in-u-of-m-clinical-trial/" rel="nofollow noopener" translate="no" target="_blank">https://kstp.com/kstp-news/top-news/long-covid-patients-urged-to-enroll-in-u-of-m-clinical-trial/</a> <a href="https://disabled.social/tags/LongCovid" class="mention hashtag" rel="nofollow noopener" target="_blank">#LongCovid</a> <a href="https://disabled.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a>

Daniel DvorkinI am a <a href="https://qoto.org/tags/medic" class="mention hashtag" rel="nofollow noopener" target="_blank">#medic</a>. If you know nothing else about me, know that.Whatever happens, wherever you are, whoever you are—call me and I will come for you. That's what medics do. That's what we are.Mostly.<a href="https://www.npr.org/2025/05/21/nx-s1-5387723/cdc-communications-cuts-social-media-public-health" rel="nofollow noopener" target="_blank">https://www.npr.org/2025/05/21/nx-s1-5387723/cdc-communications-cuts-social-media-public-health</a>I've made my living many other ways over the decades. <a href="https://qoto.org/tags/Infantry" class="mention hashtag" rel="nofollow noopener" target="_blank">#Infantry</a>, <a href="https://qoto.org/tags/writing" class="mention hashtag" rel="nofollow noopener" target="_blank">#writing</a>, <a href="https://qoto.org/tags/web" class="mention hashtag" rel="nofollow noopener" target="_blank">#web</a> development, <a href="https://qoto.org/tags/database" class="mention hashtag" rel="nofollow noopener" target="_blank">#database</a> administration, <a href="https://qoto.org/tags/teaching" class="mention hashtag" rel="nofollow noopener" target="_blank">#teaching</a>, <a href="https://qoto.org/tags/clinicaltrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#clinicaltrials</a>, <a href="https://qoto.org/tags/bioinformatics" class="mention hashtag" rel="nofollow noopener" target="_blank">#bioinformatics</a>. Maybe one of these days writing again, for more than a few months this time. All of them have shaped me to one degree or another.They're all things I did, all part of who I am. Medic is what I am. If you're lucky enough to have your own "what" as well as "who" ... well, you understand.Until World War One, more <a href="https://qoto.org/tags/soldiers" class="mention hashtag" rel="nofollow noopener" target="_blank">#soldiers</a> in every war died of <a href="https://qoto.org/tags/disease" class="mention hashtag" rel="nofollow noopener" target="_blank">#disease</a> than of <a href="https://qoto.org/tags/injuries" class="mention hashtag" rel="nofollow noopener" target="_blank">#injuries</a> received on the <a href="https://qoto.org/tags/battlefield" class="mention hashtag" rel="nofollow noopener" target="_blank">#battlefield</a>. The decreasing death toll of modern wars (you can look it up) is directly due, in large part, to advances in military public health. Those advances travel both ways, back and forth between the military and civilian worlds, preserving life all the while.<a href="https://qoto.org/tags/Epidemiology" class="mention hashtag" rel="nofollow noopener" target="_blank">#Epidemiology</a> and <a href="https://qoto.org/tags/immunology" class="mention hashtag" rel="nofollow noopener" target="_blank">#immunology</a> and <a href="https://qoto.org/tags/biostatistics" class="mention hashtag" rel="nofollow noopener" target="_blank">#biostatistics</a> and <a href="https://qoto.org/tags/environmental" class="mention hashtag" rel="nofollow noopener" target="_blank">#environmental</a> <a href="https://qoto.org/tags/medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#medicine</a> aren't TV fodder, generally speaking. It's hard to make them look glamorous. They're just the reason you're alive to read these words.<a href="https://qoto.org/tags/PublicHealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#PublicHealth</a>, taken as a whole, is unquestionably the greatest advance in medical history. Nothing else even comes close. Arguably it's the greatest advance in history, period, with no qualifiers needed.Deliberately breaking it is mass <a href="https://qoto.org/tags/murder" class="mention hashtag" rel="nofollow noopener" target="_blank">#murder</a>.I am a medic. I am also a human being. The alleged human beings responsible for this monstrosity, if they ever call me, will call in vain.

ASX Mkt. SensitiveArgenica Therapeutics ( <a href="https://mastodon-grafa.social/tags/AGN" class="mention hashtag" rel="nofollow noopener" target="_blank">#AGN</a> ) has released " New US Patent for Surgical Stroke " on Thu 22 May at 08:20 AEST <a href="https://mastodon-grafa.social/tags/UnitedStates" class="mention hashtag" rel="nofollow noopener" target="_blank">#UnitedStates</a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener" target="_blank">#Australia</a> <a href="https://mastodon-grafa.social/tags/ASX" class="mention hashtag" rel="nofollow noopener" target="_blank">#ASX</a> <a href="https://mastodon-grafa.social/tags/Tech" class="mention hashtag" rel="nofollow noopener" target="_blank">#Tech</a> <a href="https://grafa.com/asset/argenica-therapeutics-ltd-320-agn.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=agn.asx" rel="nofollow noopener" translate="no" target="_blank">https://grafa.com/asset/argenica-therapeutics-ltd-320-agn.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=agn.asx</a>

ASX Mkt. SensitiveNoxopharm ( <a href="https://mastodon-grafa.social/tags/NOX" class="mention hashtag" rel="nofollow noopener" target="_blank">#NOX</a> ) has released " New funds from Nyrada share sales " on Tue 20 May at 08:48 AEST <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener" target="_blank">#Australia</a> <a href="https://mastodon-grafa.social/tags/media" class="mention hashtag" rel="nofollow noopener" target="_blank">#media</a> <a href="https://mastodon-grafa.social/tags/ASX" class="mention hashtag" rel="nofollow noopener" target="_blank">#ASX</a> <a href="https://mastodon-grafa.social/tags/Tech" class="mention hashtag" rel="nofollow noopener" target="_blank">#Tech</a> <a href="https://grafa.com/asset/noxopharm-ltd-8713-nox.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=nox.asx" rel="nofollow noopener" translate="no" target="_blank">https://grafa.com/asset/noxopharm-ltd-8713-nox.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=nox.asx</a>

ASX Mkt. SensitiveNyrada ( <a href="https://mastodon-grafa.social/tags/NYR" class="mention hashtag" rel="nofollow noopener" target="_blank">#NYR</a> ) has released " NOX: New funds from Nyrada share sales " on Tue 20 May at 08:48 AEST <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener" target="_blank">#Australia</a> <a href="https://mastodon-grafa.social/tags/media" class="mention hashtag" rel="nofollow noopener" target="_blank">#media</a> <a href="https://mastodon-grafa.social/tags/ASX" class="mention hashtag" rel="nofollow noopener" target="_blank">#ASX</a> <a href="https://mastodon-grafa.social/tags/Tech" class="mention hashtag" rel="nofollow noopener" target="_blank">#Tech</a> <a href="https://grafa.com/asset/nyrada-inc-3430-nyr.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=nyr.asx" rel="nofollow noopener" translate="no" target="_blank">https://grafa.com/asset/nyrada-inc-3430-nyr.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=nyr.asx</a>

Alessia Visconti📣 Call for <a href="https://mas.to/tags/PhD" class="mention hashtag" rel="nofollow noopener" target="_blank">#PhD</a>: Augmenting <a href="https://mas.to/tags/clinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#clinicalTrials</a> control groups via <a href="https://mas.to/tags/SyntheticPatient" class="mention hashtag" rel="nofollow noopener" target="_blank">#SyntheticPatient</a> data <a href="https://mas.to/@berkeley" class="u-url mention" rel="nofollow noopener" target="_blank">@berkeley</a> and I may have a 3-year PhD fellowship (~1300 €/month, after taxes) at <a href="https://mas.to/tags/UniTO" class="mention hashtag" rel="nofollow noopener" target="_blank">#UniTO</a> (<a href="https://phd-csqb.campusnet.unito.it/do/home.pl" rel="nofollow noopener" translate="no" target="_blank">https://phd-csqb.campusnet.unito.it/do/home.pl</a>). Deadline: June 15th. Get in touch with us ASAP to apply!<a href="https://mas.to/tags/PhDjobs" class="mention hashtag" rel="nofollow noopener" target="_blank">#PhDjobs</a> <a href="https://mas.to/tags/ScientificCareers" class="mention hashtag" rel="nofollow noopener" target="_blank">#ScientificCareers</a> <a href="https://mas.to/tags/hiring" class="mention hashtag" rel="nofollow noopener" target="_blank">#hiring</a> <a href="https://mas.to/tags/academia" class="mention hashtag" rel="nofollow noopener" target="_blank">#academia</a>

ASX Mkt. SensitiveArcher Materials ( <a href="https://mastodon-grafa.social/tags/AXE" class="mention hashtag" rel="nofollow noopener" target="_blank">#AXE</a> ) has released " Archer partners with Paragraf for Biochip development " on Mon 19 May at 09:23 AEST <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://mastodon-grafa.social/tags/media" class="mention hashtag" rel="nofollow noopener" target="_blank">#media</a> <a href="https://mastodon-grafa.social/tags/ASX" class="mention hashtag" rel="nofollow noopener" target="_blank">#ASX</a> <a href="https://mastodon-grafa.social/tags/Business" class="mention hashtag" rel="nofollow noopener" target="_blank">#Business</a> <a href="https://mastodon-grafa.social/tags/Tech" class="mention hashtag" rel="nofollow noopener" target="_blank">#Tech</a> <a href="https://grafa.com/asset/archer-exploration-ltd-5699-axe.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=axe.asx" rel="nofollow noopener" translate="no" target="_blank">https://grafa.com/asset/archer-exploration-ltd-5699-axe.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=axe.asx</a>

Matteo CesariEnhancing the <a class="hashtag" href="https://bsky.app/search?q=%23methodology" rel="nofollow noopener" target="_blank">#methodology</a> of clinical trials in older people: A scoping <a class="hashtag" href="https://bsky.app/search?q=%23review" rel="nofollow noopener" target="_blank">#review</a> with global perspective More than 100 evidence-based recommendations to improve <a class="hashtag" href="https://bsky.app/search?q=%23ClinicalTrials" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> involving older persone <a class="hashtag" href="https://bsky.app/search?q=%23Research" rel="nofollow noopener" target="_blank">#Research</a> <a class="hashtag" href="https://bsky.app/search?q=%23Aging" rel="nofollow noopener" target="_blank">#Aging</a> <a class="hashtag" href="https://bsky.app/search?q=%23Geriatrics" rel="nofollow noopener" target="_blank">#Geriatrics</a> <a class="hashtag" href="https://bsky.app/search?q=%23Science" rel="nofollow noopener" target="_blank">#Science</a> <a class="hashtag" href="https://bsky.app/search?q=%23Care" rel="nofollow noopener" target="_blank">#Care</a> <a class="hashtag" href="https://bsky.app/search?q=%23Health" rel="nofollow noopener" target="_blank">#Health</a> 👇 <a href="https://www.sciencedirect.com/science/article/pii/S1279770725001071" rel="nofollow noopener" target="_blank">www.sciencedirect.com/science/arti...</a> <a href="https://www.sciencedirect.com/science/article/pii/S1279770725001071" rel="nofollow noopener" target="_blank">Enhancing the methodology of c...</a>

Comité pour la science ouverteInterministerial report on the importance of communicating the results of <a href="https://social.numerique.gouv.fr/tags/clinicaltrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#clinicaltrials</a> in France. The report identifies the main levers for improvement and makes operational recommendations designed to support all stakeholders involved. The aim of these recommendations is to facilitate the effective implementation of the European regulation while also promoting a culture of transparency for the benefit of research, patients and society as a whole. <a href="https://social.numerique.gouv.fr/tags/openscience" class="mention hashtag" rel="nofollow noopener" target="_blank">#openscience</a> <a href="https://www.ouvrirlascience.fr/publication-of-an-interministerial-report-on-the-importance-of-communicating-the-results-of-clinical-trials-in-france/" rel="nofollow noopener" translate="no" target="_blank">https://www.ouvrirlascience.fr/publication-of-an-interministerial-report-on-the-importance-of-communicating-the-results-of-clinical-trials-in-france/</a>

Marin Dacos - science ouvertePublication of an interministerial report on the importance of communicating the results of clinical trials in France <a href="https://www.ouvrirlascience.fr/publication-of-an-interministerial-report-on-the-importance-of-communicating-the-results-of-clinical-trials-in-france/" rel="nofollow noopener" target="_blank">https://www.ouvrirlascience.fr/publication-of-an-interministerial-report-on-the-importance-of-communicating-the-results-of-clinical-trials-in-france/</a> <a href="https://qoto.org/tags/openscience" class="mention hashtag" rel="nofollow noopener" target="_blank">#openscience</a> <a href="https://qoto.org/tags/clinicaltrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#clinicaltrials</a> <a href="https://qoto.org/tags/negativeresults" class="mention hashtag" rel="nofollow noopener" target="_blank">#negativeresults</a>

ASX News in EnglishEcho IQ raises $17.3M to drive US expansion and FDA approval for EchoSolv H... - published 07 May 2025 <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://mastodon-grafa.social/tags/ASX" class="mention hashtag" rel="nofollow noopener" target="_blank">#ASX</a> <a href="https://mastodon-grafa.social/tags/price" class="mention hashtag" rel="nofollow noopener" target="_blank">#price</a> <a href="https://mastodon-grafa.social/tags/Tech" class="mention hashtag" rel="nofollow noopener" target="_blank">#Tech</a> <a href="https://mastodon-grafa.social/tags/Strategic" class="mention hashtag" rel="nofollow noopener" target="_blank">#Strategic</a> <a href="https://grafa.com/news/health-echo-iq-raises--17-3m-to-drive-us-expansion-and-fda-approval-for-echosolv-hf-426943?utm_source=asx_news_en&utm_medium=mastodon&utm_campaign=426943" rel="nofollow noopener" translate="no" target="_blank">https://grafa.com/news/health-echo-iq-raises--17-3m-to-drive-us-expansion-and-fda-approval-for-echosolv-hf-426943?utm_source=asx_news_en&utm_medium=mastodon&utm_campaign=426943</a>

Flipboard Culture DeskCan you treat grief with a pill? Naltrexone, which is used to treat alcohol and opioid addictions, has been mooted as a way to help people with prolonged grief disorder (the premise being that they have become "addicted" to the person they lost). Ayesha Habib, whose father died when she was 21, writes for The Walrus about the many issues with this approach. "After my dad’s passing, my friends at the time grew awkward around me. They didn’t know how to speak to me, and some disappeared from my life entirely. Every person has a different way of understanding death and grief," she writes. “In a world where grief literacy is so low, I worry about our intolerance for being present with people in pain,” says Marney Thompson, the director of the bereavement services program at Victoria Hospice in British Columbia. “I think we’re so quick to jump to the solution, the fix, the ‘get over it’ that we just don’t allow space for real human emotion, which is sadness and sorrow and suffering.”<a href="https://flip.it/zOGH7d" rel="nofollow noopener" translate="no" target="_blank">https://flip.it/zOGH7d</a><a href="https://flipboard.social/tags/Grief" class="mention hashtag" rel="nofollow noopener" target="_blank">#Grief</a> <a href="https://flipboard.social/tags/Bereavement" class="mention hashtag" rel="nofollow noopener" target="_blank">#Bereavement</a> <a href="https://flipboard.social/tags/Psychology" class="mention hashtag" rel="nofollow noopener" target="_blank">#Psychology</a> <a href="https://flipboard.social/tags/Psychiatry" class="mention hashtag" rel="nofollow noopener" target="_blank">#Psychiatry</a> <a href="https://flipboard.social/tags/Science" class="mention hashtag" rel="nofollow noopener" target="_blank">#Science</a> <a href="https://flipboard.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a>

Benjamin Carr, Ph.D. 👨🏻‍💻🧬<a href="https://hachyderm.io/tags/Kennedy" class="mention hashtag" rel="nofollow noopener" target="_blank">#Kennedy</a> Issues Demands for <a href="https://hachyderm.io/tags/Vaccine" class="mention hashtag" rel="nofollow noopener" target="_blank">#Vaccine</a> Approvals That Could Affect Fall <a href="https://hachyderm.io/tags/CovidBoosters" class="mention hashtag" rel="nofollow noopener" target="_blank">#CovidBoosters</a> Health Secretary <a href="https://hachyderm.io/tags/RFK" class="mention hashtag" rel="nofollow noopener" target="_blank">#RFK</a> Jr. announced a plan that would require placebo-controlled studies for all new vaccines, surprising some experts who noted that such testing already routinely takes place. The agency suggested that <a href="https://hachyderm.io/tags/clinicaltrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#clinicaltrials</a> in humans may be required for updated <a href="https://hachyderm.io/tags/Covid" class="mention hashtag" rel="nofollow noopener" target="_blank">#Covid</a> shots, raising questions about whether they will be available in the fall. <a href="https://www.nytimes.com/2025/05/01/us/rfk-jr-vaccine-safety-placebos-covid.html" rel="nofollow noopener" translate="no" target="_blank">https://www.nytimes.com/2025/05/01/us/rfk-jr-vaccine-safety-placebos-covid.html</a> <a href="https://archive.ph/ffr54" rel="nofollow noopener" translate="no" target="_blank">https://archive.ph/ffr54</a>

Bytes EuropeNovotech CEO On Flexible Trial Solutions Amid Tariff, Geopolitical Tensions <a href="https://www.byteseu.com/956200/" rel="nofollow noopener" translate="no" target="_blank">https://www.byteseu.com/956200/</a> <a href="https://pubeurope.com/tags/AsiaPacific" class="mention hashtag" rel="nofollow noopener" target="_blank">#AsiaPacific</a> <a href="https://pubeurope.com/tags/CSuiteSpeaks" class="mention hashtag" rel="nofollow noopener" target="_blank">#CSuiteSpeaks</a> <a href="https://pubeurope.com/tags/China" class="mention hashtag" rel="nofollow noopener" target="_blank">#China</a> <a href="https://pubeurope.com/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://pubeurope.com/tags/cro" class="mention hashtag" rel="nofollow noopener" target="_blank">#cro</a> <a href="https://pubeurope.com/tags/Geopolitics" class="mention hashtag" rel="nofollow noopener" target="_blank">#Geopolitics</a> <a href="https://pubeurope.com/tags/Interviews" class="mention hashtag" rel="nofollow noopener" target="_blank">#Interviews</a> <a href="https://pubeurope.com/tags/tariffs" class="mention hashtag" rel="nofollow noopener" target="_blank">#tariffs</a>

Dining & CookingLeading Nutrition Scientist Departs N.I.H., Citing Censorship <a href="https://www.diningandcooking.com/2021174/leading-nutrition-scientist-departs-n-i-h-citing-censorship/" rel="nofollow noopener" translate="no" target="_blank">https://www.diningandcooking.com/2021174/leading-nutrition-scientist-departs-n-i-h-citing-censorship/</a> <a href="https://vive.im/tags/Censorship" class="mention hashtag" rel="nofollow noopener" target="_blank">#Censorship</a> <a href="https://vive.im/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://vive.im/tags/DietAndNutrition" class="mention hashtag" rel="nofollow noopener" target="_blank">#DietAndNutrition</a> <a href="https://vive.im/tags/food" class="mention hashtag" rel="nofollow noopener" target="_blank">#food</a> <a href="https://vive.im/tags/GovernmentEmployees" class="mention hashtag" rel="nofollow noopener" target="_blank">#GovernmentEmployees</a> <a href="https://vive.im/tags/NationalInstitutesOfHealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#NationalInstitutesOfHealth</a> <a href="https://vive.im/tags/nutrition" class="mention hashtag" rel="nofollow noopener" target="_blank">#nutrition</a> <a href="https://vive.im/tags/ProcessedAndUltraprocessedFoods" class="mention hashtag" rel="nofollow noopener" target="_blank">#ProcessedAndUltraprocessedFoods</a> <a href="https://vive.im/tags/Research" class="mention hashtag" rel="nofollow noopener" target="_blank">#Research</a> <a href="https://vive.im/tags/UnitedStatesPoliticsAndGovernment" class="mention hashtag" rel="nofollow noopener" target="_blank">#UnitedStatesPoliticsAndGovernment</a>

ASX News in EnglishInhaleRx appoints iNGENū CRO for Phase 1 clinical trial of IRX-616a - published 17 Apr 2025 <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener" target="_blank">#Australia</a> <a href="https://mastodon-grafa.social/tags/ASX" class="mention hashtag" rel="nofollow noopener" target="_blank">#ASX</a> <a href="https://mastodon-grafa.social/tags/Tech" class="mention hashtag" rel="nofollow noopener" target="_blank">#Tech</a> <a href="https://mastodon-grafa.social/tags/BioTech" class="mention hashtag" rel="nofollow noopener" target="_blank">#BioTech</a> <a href="https://grafa.com/news/health-inhalerx-appoints-ingen--cro-for-phase-1-clinical-trial-of-irx-616a-424512?utm_source=asx_news_en&utm_medium=mastodon&utm_campaign=424512" rel="nofollow noopener" translate="no" target="_blank">https://grafa.com/news/health-inhalerx-appoints-ingen--cro-for-phase-1-clinical-trial-of-irx-616a-424512?utm_source=asx_news_en&utm_medium=mastodon&utm_campaign=424512</a>

ASX Mkt. SensitiveArgenica Therapeutics ( <a href="https://mastodon-grafa.social/tags/AGN" class="mention hashtag" rel="nofollow noopener" target="_blank">#AGN</a> ) has released " Last Patient Dosed in Phase 2 Stroke Trial " on Fri 11 Apr at 08:21 AEST <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener" target="_blank">#Australia</a> <a href="https://mastodon-grafa.social/tags/ASX" class="mention hashtag" rel="nofollow noopener" target="_blank">#ASX</a> <a href="https://mastodon-grafa.social/tags/Tech" class="mention hashtag" rel="nofollow noopener" target="_blank">#Tech</a> <a href="https://mastodon-grafa.social/tags/BioTech" class="mention hashtag" rel="nofollow noopener" target="_blank">#BioTech</a> <a href="https://grafa.com/asset/argenica-therapeutics-ltd-320-agn.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=agn.asx" rel="nofollow noopener" translate="no" target="_blank">https://grafa.com/asset/argenica-therapeutics-ltd-320-agn.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=agn.asx</a>

asx_news_deTryptamine Therapeutics arbeitet mit der Swinburne University an einer Stud... - published 10 Apr 2025 <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://mastodon-grafa.social/tags/ASX" class="mention hashtag" rel="nofollow noopener" target="_blank">#ASX</a> <a href="https://mastodon-grafa.social/tags/Tech" class="mention hashtag" rel="nofollow noopener" target="_blank">#Tech</a> <a href="https://mastodon-grafa.social/tags/Grafa" class="mention hashtag" rel="nofollow noopener" target="_blank">#Grafa</a> <a href="https://mastodon-grafa.social/tags/Technology" class="mention hashtag" rel="nofollow noopener" target="_blank">#Technology</a> <a href="https://grafa.com/news/de-health-tryptamine-therapeutics-teams-up-with-swinburne-university-for-binge-eating-disorder-trial-419565?utm_source=asx_news_de&utm_medium=mastodon&utm_campaign=419565" rel="nofollow noopener" translate="no" target="_blank">https://grafa.com/news/de-health-tryptamine-therapeutics-teams-up-with-swinburne-university-for-binge-eating-disorder-trial-419565?utm_source=asx_news_de&utm_medium=mastodon&utm_campaign=419565</a>

Recent searches

Search options

Administered by:

Server stats:

#clinicaltrials